Delphine PrecisQT™ COVID-19 Test Kit has been accepted for distribution under Section IV.C.2 of the FDA’s Policy for Coronavirus Diseases-2019 Tests.
Our vision is to enhance human Healthcare by engaging in the development and supply of best- in-class, affordable products for diagnostics; and provide value added services like data insights capabilities on a long-term basis
Delphine Diagnostics, a New Jersey-based start-up, is passionate in its efforts to deliver best-in-class diagnostics products to speed effective treatment for patients with infectious diseases. The affordability and reliability of our innovative products guide our journey.
We will be distributing test kits to established Diagnostics Lab Networks across the United States.